GGrantIndex
← Leaderboards

Nemametrix, Inc.

Eugene, OR

Compare ↔
$6,798,940
Total funding
11
Grants

Funding over time

peak $1.6M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,798,940 · 11

By mechanism

R44$3,790,880 · 2
R43$3,008,060 · 9

Investigators at Nemametrix, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities$1,289,868
R44 · FY2024 · OD
Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities$1,126,155
R44 · FY2025 · OD
Function-based Variant Assessment of Epilepsome Genes to Increase Diagnostic Yield$664,094
R43 · FY2019 · NS
Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms$510,448
R44 · FY2018 · GM
Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms$475,637
R44 · FY2019 · GM
DanFreez: Zebrafish Genetically-Optimized for Cryogenic Storage of Embryos$464,655
R43 · FY2022 · OD
Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities$388,772
R44 · FY2023 · OD
Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping.$350,000
R43 · FY2020 · HG
Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia$350,000
R43 · FY2018 · AG
The ToxiFin Platform: Advancing High-Throughput Screening and Mechanistic Insights For Developmental Neurotoxicants Using the Zebrafish Model$296,420
R43 · FY2024 · ES
Humanized LMNA Animal Model for Detecting Pathogenicity in Clinical Variants$225,000
R43 · FY2019 · GM
Resubmission: Systems for Exploring Pathogenicity in Clinical Variants of a Presynaptic Protein Involved in Epilepsy$224,703
R43 · FY2019 · NS
Microfluidic screening devices for health-span extending drugs$158,406
R43 · FY2014 · AG
Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms$149,850
R43 · FY2016 · GM
Administrative Supplement: Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping.$124,932
R43 · FY2021 · HG
Nemametrix, Inc. · GrantIndex